Artist: Michael Jurogue Johnson

Please Contact Me

Down Syndrome Clinical Research Study in Australia

A compound in a medicine used for decades, may improve learning for people with Down syndrome


Research from Stanford University, funded in part by the LuMind Foundation, has identified a compound for its potential to improve memory, language, and learning in people with Down syndrome.

We are now running a clinical study for persons with Down syndrome age 13 to 35 years old to evaluate whether this treatment has any effectiveness.

The Study is currently approved in Adelaide, Launceston, Melbourne, Perth, Sydney, and Wollongong.

Find out if you are eligible to participate.
Call 1300 659 729 (free call) or you can email info@compose21.com.